HPV DNA Pap Test Approved As Primary Screen; New Guidelines Expected
This article was originally published in The Gray Sheet
Executive Summary
Digene is evaluating various methods of marketing its human papillomavirus (HPV) test to ob/gyn physicians following expanded approval for primary cervical cancer screening March 31